PREVALENCE OF NEONATAL SEPSIS AMONG NEWBORNS UNIT AND ANTIMICROBIALS IS USED IN HOSPITALS GOVERNMENT AND PRIVATE IN SANA'A, YEMEN

Background: Nearly 3 million newborns suffer from sepsis globally each year and sepsis is considered one of the leading causes of morbidity and mortality in neonates, despite recent advances in health care units. The main burden of the problem falls on the developing world. Objective: The current study aimed to evaluate the prevalence of Neonatal sepsis among newborns unit and antimicrobials is used in government and private hospitals in Sana’a, Yemen. Methods: The current study aimed to evaluate the prevalence of Neonatal sepsis among newborns unit and antimicrobials is used in government and private hospitals in Sana’a, Yemen. A cross-sectional study was conducted on (200) children suspected of having neonatal sepsis from both hospitals (100government, 100 private) in the period from (1January, 2024 until 30April, 2024). Medical information on the newborns was collected using a structured questionnaire. The sample has been examined of members to confirm the growth of the pathogen, its type, and the degree sensitivity and resistance to the antibiotics that were used during treatment. Data were collected and analysed using (SPSS.V25) program and tested using Chi square to verify the extent of relationships between variables within the study at the significance level (P